---
title: "DC 5329 - Sarcoma, soft tissue (of muscle, fat, or fibrous connective tissue)â100"
diagnostic_code: "5329"
body_system: "Muscle Injuries"
cfr_section: "§ 4.73"
canonical: "https://veteranai.co/va-rating-schedule/muscle-injuries/5329-sarcoma-soft-tissue-of-muscle-fat-or-fibrous-connective"
source: "https://www.ecfr.gov/current/title-38/section-4.73"
updated: "2026-07-21T20:11:35.424390Z"
---

# DC 5329 - Sarcoma, soft tissue (of muscle, fat, or fibrous connective tissue)â100

Rated under § 4.73. Body system: Muscle Injuries.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Sarcoma, soft tissue (of muscle, fat, or fibrous connective tissue)â100 |

## Notes

- Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residual impairment of function.

# Soft Tissue Sarcoma (Diagnostic Code 5329)

**VA Disability Rating for Soft Tissue Sarcoma — 38 CFR § 4.73, Muscle Injuries**

## What This Condition Is

Soft tissue sarcoma is a cancer that develops in the muscle, fat, or fibrous connective tissue. Under the VA rating schedule, it falls within the Muscle Injuries body system and is evaluated under Diagnostic Code 5329 in § 4.73.

## Available Rating Level

Under Diagnostic Code 5329, there is a single scheduled rating level:

| Rating | Criteria |
| ------ | -------- |
| **100%** | Sarcoma, soft tissue (of muscle, fat, or fibrous connective tissue) |

## What the VA Looks For When Rating This Condition

The 100 percent rating is assigned during active disease and treatment. Specifically, the VA applies the following rules:

- **The 100 percent rating continues** beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures.
- **Six months after such treatment is discontinued**, the appropriate disability rating is determined by a mandatory VA examination.
- **Any change in the evaluation** based on that examination — or any subsequent examination — is subject to the provisions of § 3.105(e).
- **If there has been no local recurrence or metastasis**, the condition is rated based on the residual impairment of function.

*This information is drawn directly from the VA rating schedule (38 CFR § 4.73, Diagnostic Code 5329). It is provided for general educational purposes and describes how the condition is scheduled — it is not a prediction of any individual outcome.*

Source: https://www.ecfr.gov/current/title-38/section-4.73